-
-
-
-
-
-
-
YS Biopharma Granted Phase I Clinical Trial License of Therapeutic Chronic Hepatitis B Virus Vaccine
-
-
-
-
-
-
-
YS Biopharma Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2024
15,821 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

